Homology Medicines, Inc.
NASDAQ:FIXX
0.9347 (USD) • At close March 25, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | 2017 Q4 | 2017 Q3 | 2017 Q2 | 2017 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 1.418 | 0 | 0.354 | 0.802 | 0.802 | 0.802 | 0.802 | 0.802 | 0.802 | 1.677 | 2.187 | 29.305 | 0.98 | 0.567 | 0.567 | 0.588 | 0.563 | 0.441 | 0.392 | 0.27 | 0.98 | 0.954 | 0.926 | 0.823 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0 | 1.287 | 0.136 | 0.564 | 0.587 | 0.633 | 0.635 | 0.786 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 0 | 0.131 | -0.136 | -0.21 | 0.215 | 0.169 | 0.167 | 0.016 | 0.802 | 0.802 | 1.677 | 2.187 | 29.305 | 0.98 | 0.567 | 0.567 | 0.588 | 0.563 | 0.441 | 0.392 | 0.27 | 0.98 | 0.954 | 0.926 | 0.823 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0 | 0.092 | 0 | -0.593 | 0.268 | 0.211 | 0.208 | 0.02 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 9.841 | 1.513 | 17.519 | 22.982 | 19.988 | 27.149 | 25.854 | 21.075 | 24.273 | 23.646 | 23.987 | 23.697 | 21.755 | 23.195 | 20.417 | 27.471 | 29.31 | 20.342 | 25.691 | 22.827 | 20.536 | 16.281 | 13.394 | 10.29 | 7.998 | 9.576 | 4.947 | 4.056 | 2.799 |
| General & Administrative Expenses
| 5.002 | 7.901 | 6.842 | 8.188 | 8.325 | 8.147 | 7.81 | 8.034 | 14.147 | 10.781 | 8.351 | 9.042 | 8.661 | 7.587 | 8.423 | 8.793 | 7.77 | 5.78 | 6.038 | 5.538 | 4.857 | 5.087 | 3.843 | 4.527 | 3.828 | 2.686 | 1.718 | 1.982 | 1.892 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 5.002 | 7.901 | 6.842 | 8.188 | 8.325 | 8.147 | 7.81 | 8.034 | 14.147 | 10.781 | 8.351 | 9.042 | 8.661 | 7.587 | 8.423 | 8.793 | 7.77 | 5.78 | 6.038 | 5.538 | 4.857 | 5.087 | 3.843 | 4.527 | 3.828 | 2.686 | 1.718 | 1.982 | 1.892 |
| Other Expenses
| 0 | 2.687 | 6.64 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.876 |
| Operating Expenses
| 14.843 | 9.414 | 31.001 | 31.17 | 28.313 | 35.296 | 33.664 | 29.109 | 38.42 | 34.427 | 32.338 | 32.739 | 30.416 | 30.782 | 28.84 | 36.264 | 37.08 | 26.122 | 31.729 | 28.365 | 25.393 | 21.367 | 17.237 | 14.817 | 11.826 | 12.263 | 6.665 | 6.039 | 4.692 |
| Operating Income
| -14.843 | -9.414 | -31.001 | -30.816 | -27.511 | -34.494 | -32.862 | -28.307 | -37.618 | -33.625 | -30.661 | -30.552 | -1.111 | -29.802 | -28.273 | -35.697 | -36.492 | -25.559 | -31.288 | -27.973 | -25.123 | -20.387 | -16.283 | -13.891 | -11.002 | -12.263 | -6.665 | -6.039 | -4.692 |
| Operating Income Ratio
| 0 | -6.639 | 0 | -87.051 | -34.303 | -43.01 | -40.975 | -35.296 | -46.905 | -41.926 | -18.283 | -13.97 | -0.038 | -30.41 | -49.864 | -62.958 | -62.061 | -45.398 | -70.948 | -71.36 | -93.048 | -20.803 | -17.065 | -14.993 | -13.362 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 16.048 | 7.259 | 1.423 | 1.511 | 1.469 | 1.455 | 1.269 | 0.474 | 131.281 | 0.042 | 0.053 | 0.052 | 0.038 | 0.011 | 0.041 | 0.357 | 1.161 | 1.392 | 1.661 | 1.703 | 1.271 | 1.386 | 2.135 | 1.465 | 0.785 | 0.357 | 0.137 | 0.036 | -0.863 |
| Income Before Tax
| 1.205 | -2.155 | -29.578 | -29.305 | -26.042 | -33.039 | -31.593 | -27.833 | 93.663 | -33.583 | -30.608 | -30.5 | -1.073 | -29.791 | -28.232 | -35.34 | -35.331 | -24.167 | -29.627 | -26.27 | -23.852 | -19.001 | -14.796 | -12.894 | -10.523 | -11.906 | -6.528 | -6.003 | -5.555 |
| Income Before Tax Ratio
| 0 | -1.52 | 0 | -82.782 | -32.471 | -41.196 | -39.393 | -34.704 | 116.787 | -41.874 | -18.252 | -13.946 | -0.037 | -30.399 | -49.792 | -62.328 | -60.087 | -42.925 | -67.181 | -67.015 | -88.341 | -19.389 | -15.507 | -13.917 | -12.78 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0.176 | 13.964 | 3.376 | 5.739 | 2.802 | -0.101 | -0.046 | -0.105 | 0.967 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.013 |
| Net Income
| 1.029 | -16.119 | -32.954 | -35.044 | -28.844 | -32.938 | -31.547 | -27.728 | 92.105 | -33.583 | -30.608 | -30.5 | -1.073 | -29.791 | -28.232 | -35.34 | -35.331 | -24.167 | -29.627 | -26.27 | -23.852 | -19.001 | -14.796 | -12.894 | -10.523 | -11.906 | -6.528 | -6.003 | -5.555 |
| Net Income Ratio
| 0 | -11.367 | 0 | -98.994 | -35.965 | -41.07 | -39.335 | -34.574 | 114.844 | -41.874 | -18.252 | -13.946 | -0.037 | -30.399 | -49.792 | -62.328 | -60.087 | -42.925 | -67.181 | -67.015 | -88.341 | -19.389 | -15.507 | -13.917 | -12.78 | 0 | 0 | 0 | 0 |
| EPS
| 1.03 | -50.01 | -102.53 | -109.14 | -89.96 | -103.14 | -99.34 | -87.5 | 1.61 | -106.01 | -97.2 | -97.2 | -3.83 | -118.57 | -112.36 | -140.71 | -140.85 | -98.95 | -121.46 | -109.77 | -114.84 | -93.3 | -71.45 | -62.97 | -42.09 | -115.2 | -63.16 | -58.08 | -53.75 |
| EPS Diluted
| 0.44 | -50.01 | -102.53 | -109.14 | -89.96 | -103.14 | -98.85 | -86.97 | 1.59 | -105.85 | -96.48 | -97.17 | -3.83 | -118.57 | -112.36 | -140.71 | -140.85 | -96.34 | -121.46 | -109.77 | -114.84 | -91.49 | -71.45 | -62.97 | -42.09 | -115.2 | -63.16 | -58.08 | -53.75 |
| EBITDA
| -14.843 | -1.264 | -17.585 | -30.599 | -27.286 | -34.198 | -32.227 | -27.979 | -37.618 | -31.552 | -28.562 | -28.451 | 0.969 | -27.746 | -26.263 | -33.926 | -34.364 | -23.84 | -29.597 | -26.331 | -23.857 | -19.824 | -16.283 | -13.891 | -11.002 | -12.062 | -6.475 | -5.875 | -4.561 |
| EBITDA Ratio
| 0 | -6.639 | 0 | -86.438 | -34.022 | -42.641 | -40.575 | -34.887 | -210.123 | -39.342 | -17.032 | -13.009 | 0.033 | -28.312 | -46.319 | -59.834 | -58.442 | -42.345 | -67.113 | -67.171 | -88.359 | -20.229 | -16.785 | -14.737 | -13.095 | 0 | 0 | 0 | 0 |